Home
TiGenix N.V.

TiGenix N.V. Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domaintigenix.com

Year Founded2000

Employees51 - 200

Annual Revenue$50M - $75M

TiGenix N.V.

TiGenix N.V. (including company regionals)

tigenix.com

See more website traffic and engagement information

TiGenix N.V. Revenue up to November 2025 is 50M - 75M

revenue generated by TiGenix N.V. top domains

TiGenix N.V. top domains revenue over 3 years

Revenue for TiGenix N.V. top domains

tigenix.com50M - 75M

See more with Sales Intelligence

Total visits to TiGenix N.V.'s top domains

Understand TiGenix N.V. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in TiGenix N.V.'s top domains

Analyze TiGenix N.V. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on TiGenix N.V.'s top domains

See how TiGenix N.V. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

TiGenix N.V. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

toxikon.comCompany NameToxikonEmployees51 - 200HQUnited States, Massachusetts, BedfordAnnual revenue$25M - $50MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by TiGenix N.V.

These are the website technologies, by industry, used by TiGenix N.V. top domains

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

Mobile (3)

Meta Viewport

Payment & Currencies (3)

Euro

More Technologies

5

See all

News & Signals from TiGenix N.V.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovo Nordisk A/S acquired TiGenix on Oct 1st '21.Novo Nordisk and TiGenix: In October 2021, Novo Nordisk announced its acquisition of TiGenix, a regenerative medicine company focused on developing stem cell therapies.

NewsTakeda in Belgium acquires TiGenix for $1B.Prior to this, Dr. Leselbaum was Director Clinical Development at Tigenix, which was acquired by Takeda for more than half a billion euros.

NewsTakeda acquires TiGenix for $559M.Already on the first day of the J.P. Morgan Conference, Celgene announced its staged $7B acquisition of Impact Biomedicines while Takeda announced its agreement to acquire TiGenix for €520MM.